Conclusions Organoids treated with MMC or 200 mg/㎡ heated oxaliplatin for 2 h displayed increased susceptibility in comparison with 30-min 460 mg/㎡ oxaliplatin. Optimal perfusion protocol varies among patients, and organoid technology may offer a platform for tailoring HIPEC conditions to the individual patient level.